EU PROJECTS

call for expressions of interest

As part of the Joint Action “Supporting the increased capacity and competence building of the EU medicines regulatory network” (IncreaseNET), funded under the EU4Health programme ...
READ MORE

Sustainability workshop of JAMS 2.0 outcomes

Agency for Medicinal Products and Medical Devices of the Republic of Slovenia (JAZMP), as the leader of Work Package 4 Sustainability within the EU4Health joint ...
READ MORE

Meeting of Members of the European Integrated Price Information Database (EURIPID)

Agency for Medicinal Products and Medical Devices of the Republic of Slovenia (JAZMP) hosted members of the European Integrated Price Information Database (EURIPID) on May ...
READ MORE

Simultaneous National Scientific Advice (SNSA) – Continuation and further development during 2025

Since February 2020, the EU Innovation Network (EU-IN) has been running a pilot project for simultaneous national scientific advice (SNSA) from national competent authorities (NCAs). ...
READ MORE

IncreaseNET: A One-Year Progress Overview

Since its launch on January 1, 2024, IncreaseNET has been dedicated to strengthening collaboration, knowledge-sharing, and training within the European Medicines Regulatory Network (EMRN). Over ...
READ MORE

CHESSMEN Joint Action Wrap-Up 2024

The CHESSMEN project has reached month 24.  A summary of the main activities carried out in 2024 can be found at this link.
READ MORE

PROJECTS DESCRIPTION

INCREASENET

Supporting the increased capacity and competence building of the EU medicines regulatory network

EU-JAMRAI 2

Joint Action Antimicrobial Resistance and Healthcare-Associated Infections 2

JAMS 2.0

Reinforced market surveillance of medical devices and in-vitro devices

CHESSMEN

Coordination and Harmonisation of the Existing Systems against Shortages of Medicines – European Network

EURIPID

Development of early warning features and guidance in the area of pricing through the EURIPID database

EU4H 11

Joint Action on quality of medicines and implementation of the pharmaceutical legislation/strategy

SAFE CT

Safety assessment cooperation and facilitated conduct of clinical trials


CT CURE

Clinical Trial Competitive multinational assessment timelines in the European Union ensuring Regulatory Excellence

attachment large
Scroll to Top